All In MedTech

FDA Clearance Tracker · P100049-S011

LINX REFLUX MANAGEMENT SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 21, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 21, 2015

Approved

Time to decision

86 days

Received Oct 27, 2014. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P100049-S011
Device name
LINX REFLUX MANAGEMENT SYSTEM
Applicant
Torax Medical
Applicant location
Cincinnati, OH
Received
Oct 27, 2014
Decided
Jan 21, 2015
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P100049

Device type

Device class
Class III

Every decision under product code LEI

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATIONS TO THE INTERNAL MAGNETS AND WIRE LINKS CONNECTING THE BEADS, AS WELL AS ASSOCIATED MODIFICATIONS TO THE LABELING, ALLOWING THE DEVICE TO BE MAGNETIC RESONANCE (MR) CONDITIONAL UP TO 1.5 TESLA.

Source documents

Other decisions for Torax Medical

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.